NEW YORK – Merck KGaA, Darmstadt, Germany, and Artios Pharma on Thursday announced a three-year research pact to discover and develop precision oncology drugs that inhibit the biological mechanisms that cancer cells use to repair DNA damage and proliferate.
To read the full story....
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.